122 related articles for article (PubMed ID: 7390672)
1. The influence of renal function on the elimination kinetics of sulbenicillin in man.
Montanari A; Borghi L; Canali M; Coruzzi P; Novarini A; Borghetti A
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):225-8. PubMed ID: 7390672
[TBL] [Abstract][Full Text] [Related]
2. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Kirch W; Köhler H; Berggren G; Braun W
Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
[TBL] [Abstract][Full Text] [Related]
3. Sulbenicillin: pharmacokinetics and penetration into bronchial secretion in elderly patients.
Ripa S; Mignini F; Patrizi I; Ferrante L; Prenna M; Falcioni E
Chemioterapia; 1987 Aug; 6(4):277-81. PubMed ID: 3652279
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of nimodipine in normal and impaired renal function.
Kirch W; Rämsch KD; Dührsen U; Ohnhaus EE
Int J Clin Pharmacol Res; 1984; 4(5):381-4. PubMed ID: 6519852
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profile of benoxaprofen in subjects with normal and impaired renal function, prediction of multiple-dose kinetics.
Brogard JM; Comte F; Madon M; Spach MO
Eur J Rheumatol Inflamm; 1982; 5(2):113-23. PubMed ID: 7084275
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the new broad spectrum penicillin CP-33994-2.
Bergan T; Brodwall EK; Orjavik O
Arzneimittelforschung; 1980; 30(7):1144-7. PubMed ID: 7191297
[TBL] [Abstract][Full Text] [Related]
8. Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections.
Joos B; Luethy R; Muehlen E; Siegenthaler W
Am J Med; 1984 Oct; 77(4C):59-62. PubMed ID: 6093521
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of indoprofen in patients with renal insufficiency (a preliminary report).
Wibell L; Nilsson P; Lindström B
Eur J Rheumatol Inflamm; 1981; 4(1):16-21. PubMed ID: 7341276
[TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutical studies on pyridinolcarbamate. V. Effect of repeated administration of pyridinolcarbamate on the renal excretion of sulbenicillin in rabbits.
Suenaga A; Nakagawa H; Huang MT; Imamura Y; Otagiri M; Ichibagase H
Acta Pharm Suec; 1985; 22(1):45-52. PubMed ID: 4024967
[No Abstract] [Full Text] [Related]
11. [Update on antibiotic therapy. 16) Sulbenicillin].
Di Nola F
Minerva Med; 1983 Apr; 74(18):1073-6. PubMed ID: 6678394
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics of ceftazidime in normal and impaired renal function.
Höffler D; Koeppe P; Williams KJ
Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the intravenous administration of sulbenicillin (author's transl)].
Kato Y; Saito A; Yajima O; Tomizawa M; Nakayma I
Jpn J Antibiot; 1976 Apr; 29(4):358-65. PubMed ID: 778428
[TBL] [Abstract][Full Text] [Related]
14. Cephacetrile--application of pharmacokinetic data to dosage determination.
Brogard JM; Dorner M; Brandt C; Lavillaureix J
Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):168-76. PubMed ID: 950258
[TBL] [Abstract][Full Text] [Related]
15. [Benoxaprofene: pharmacokinetic profile in the normal subject and patients with renal insufficiency; evaluation of anticipated serum levels].
Brogard JM; Audhuy B; Spach MO
Schweiz Med Wochenschr; 1981 Feb; 111(6):197-201. PubMed ID: 7221526
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of fleroxacin in renal impairment.
Weidekamm E
Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
[TBL] [Abstract][Full Text] [Related]
17. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
18. Effects of renal function on recainam pharmacokinetics and pharmacodynamics.
Cheng JW; Charland SL; Goldfarb S; Spinler SA
Clin Pharmacol Ther; 1995 May; 57(5):492-8. PubMed ID: 7768071
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefapirin in patients with normal and impaired renal functions.
Bergan T; Orjavik O; Brodwall EK
Arzneimittelforschung; 1981; 31(10):1773-6. PubMed ID: 7198453
[TBL] [Abstract][Full Text] [Related]
20. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
